Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

TENX holding history

Tenax Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TENX overviewAll 13F holders of TENXFull Q2 2026 holdings

Shares (Q2 2026)
432,220
Value
$6.29M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TENX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026432,220$6.29M<0.1%−164,344−27.5%ReducedHolders
Q1 2026596,564$9.54M<0.1%+1880.0%AddedHolders
Q4 2025596,376$7.27M<0.1%+418,047+234.4%AddedHolders
Q3 2025178,329$1.36M<0.1%+319+0.2%AddedHolders
Q2 2025178,010$1.03M<0.1%+56,916+47.0%AddedHolders
Q1 2025121,094$793.2K<0.1%+46,649+62.7%AddedHolders
Q4 202474,445$460.8K<0.1%+74,185+28,532.7%AddedHolders
Q3 2024260$900<0.1%00.0%UnchangedHolders
Q2 2024260$784<0.1%00.0%UnchangedHolders
Q1 2024260$1.10K<0.1%−20,417−98.7%ReducedHolders
Q4 202320,677$5.68K<0.1%+20,002+2,963.3%AddedHolders
Q3 2023675$202<0.1%−5−0.7%ReducedHolders
Q2 2023680$205<0.1%00.0%UnchangedHolders
Q1 2023680$316<0.1%−12,920−95.0%ReducedHolders
Q4 202213,600$1.51K<0.1%−40.0%ReducedHolders
Q3 202213,604$2.00K<0.1%+13,604NewHolders
Q2 20220$00.0%−12−100.0%Sold outHolders
Q1 202212$00.0%+11+1,100.0%AddedHolders
Q4 20211$00.0%−1−50.0%ReducedHolders
Q3 20212$00.0%−38,648−100.0%ReducedHolders
Q2 202138,650$80.0K<0.1%+38,648+1,932,400.0%AddedHolders
Q1 20212$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.